Furthermore, ZBED3 displays significant correlations with various clinical parameters, including enhanced lymph node metastasis, advanced TNM stages, elevated Ki67 expression, and unfavorable clinical outcomes [31, 32]. The gene discussed is MKI67; the disease is metastatic malignant neoplasm in the lymph nodes.